A look into how AES rapidly responded to the nations need for new manufacturing space for COVID 19 vaccine production. Learn the details on the challenges faced and how the AES organization mobilized to help the United States government and pharmaceutical companies rapidly build the necessary infrastructure to manufacture COVID19 vaccines.
In this webinar you’ll learn:
The additional challenges COVID presented to already compressed timelines and the strategies AES utilized to rapidly mobilize and meet the country’s needs
The unique solutions AES used in WARP speed projects
How pharma bio companies can leverage new technology developed to reduce time to patient
Who should attend:
Pharma Bio Executives
Manufacturing Professionals
Quality Professionals
Engineering, Architecture, and Construction Professionals
Presenters
Josh Russell
(Presenter) Vice President of Sales & Marketing AES Clean Technology View Biography
Jose Jimenez
(Presenter) Vice President of Construction AES Clean Technology View Biography
Mike Auerbach
(Moderator) Editor-in-Chief, American Pharmaceutical Review